Johnson And Johnson Revenue per Employee (JNJ), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Johnson and Johnson  (NYSE: JNJ)
 

Johnson And Johnson's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 6.6% in the second quarter 2026, year on year to cumulative value of $97,929 million, Johnson And Johnson's revenue per employee grew on a trailing twelve months basis to $ 695,518, this marks a new company high.
Within the Healthcare sector Employees of 129 other companies have achieved higher revenue per employee. While Johnson And Johnson's total ranking has deteriorated compared to the previous quarter from 67 to 1220. Johnson And Johnson has 140,800 employees.


What is Sales per Employee Ratio?







JNJ Revenue per Employee (Jun 28 2026)
II. Quarter
(Mar 29 2026)
I. Quarter
(Dec 28 2025)
IV. Quarter
(Sep 28 2025)
III. Quarter
(Jun 29 2025)
II. Quarter
Y / Y Revenue Change 6.6 % 9.91 % 9.08 % 6.77 % 5.77 %
Sales per Employee (TTM) $ 695,518 684,389 668,984 654,467 643,658
JNJ's Total Ranking # 1220 # 67 # 225 # 65 # 80
Seq. Revenue Change 5.19 % -2.04 % 2.38 % 1.05 % 8.45 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 130
Overall Market # 1220

Revenue per Employee Statistics
High Average Low
$ 695,518 $ 531,813 $ 358,764
(Jun 28 2026)   (Dec. 30. 2005)



Financial Statements
Johnson And Johnson's Revenue MRQ $ 25,310 Millions Visit JNJ's Income Statement
Johnson And Johnson's Revenues TTM $ 97,929 Millions Visit JNJ's aggregate revenue growth
What are JNJ's Sales? Visit JNJ's Sales by Segment




Other Ratios
Johnson And Johnson's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
JNJ's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for JNJ's Competitors
Revenue per Employee for JNJ's Suppliers
Revenue per Employee for JNJ's Customers

You may also want to know
JNJ's Sales Growth Rates JNJ's Pe Price to earnings ratio JNJ's Receivables Turnover Ratio JNJ's Stock Quote
JNJ's Net Income Growth Rates JNJ's Ps Price to Sales ratio JNJ's Sales per Employee JNJ's Asset Turnover Ratio
JNJ's Net Margin JNJ's Pb Price to Book ratio JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
Date modified: 2026-09-05T07:03:42+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 28 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 28 2026Number of Employees Jun 28 2026
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.